Apurva Sood

1PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 21, 2021
177Lu-DOTATATE Plus Radiosensitizing Capecitabine Versus Octreotide Long-Acting Release as First-Line Systemic Therapy in Advanced Grade 1 or 2 Gastroenteropancreatic Neuroendocrine Tumors: A Single-Institution Experience.

Swayamjeet Satapathy, Bhagwant R Mittal, Ashwani Sood

Pageof 1

Frequent Collaborators

1 joint publications

Bhagwant R Mittal

1 joint publications

Ashwani Sood

1 joint publications

Rakesh Kapoor

1 joint publications

Rajesh Gupta